Published in Br J Pharmacol on August 01, 1999
The mitochondrial origin of postischemic arrhythmias. J Clin Invest (2005) 3.08
Thiazolidinedione drugs block cardiac KATP channels and may increase propensity for ischaemic ventricular fibrillation in pigs. Diabetologia (2008) 0.93
Mitochondrial KATP channel inhibition blunts arrhythmia protection in ischemic exercised hearts. Am J Physiol Heart Circ Physiol (2010) 0.92
KATP Channels in the Cardiovascular System. Physiol Rev (2016) 0.82
Thrombin receptor and ventricular arrhythmias after acute myocardial infarction. Mol Med (2008) 0.81
Role of KATP channel in electrical depression and asystole during long-duration ventricular fibrillation in ex vivo canine heart. Am J Physiol Heart Circ Physiol (2012) 0.80
Rabbit ventricular myocardium undergoing simulated ischemia and reperfusion in a double compartment tissue bath: a model to investigate both antiarrhythmic and arrhythmogenic likelihood. Int J Physiol Pathophysiol Pharmacol (2013) 0.77
Blockers of ATP sensitive potassium current are of potential benefit in ischaemic heart disease. Cardiovasc Res (1994) 3.33
Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet (1994) 1.99
Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection? Cardiovasc Res (1995) 1.69
Pharmacological evidence for the persistent activation of ATP-sensitive K+ channels in early phase of reperfusion and its protective role against myocardial stunning. Circulation (1995) 1.67
Effects of glibenclamide on ventricular arrhythmias and cardiac function in ischaemia and reperfusion in isolated rat heart. Cardiovasc Res (1992) 1.45
ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage. Circ Res (1991) 1.29
Comparison of the effects of regional ischemia, hypoxia, hyperkalemia, and acidosis on intracellular and extracellular potentials and metabolism in the isolated porcine heart. Circ Res (1980) 1.16
Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation (1994) 1.14
The "border zone" in myocardial ischemia. An electrophysiological, metabolic, and histochemical correlation in the pig heart. Circ Res (1979) 1.02
Potential electrophysiologic mechanisms responsible for dysrhythmias associated with reperfusion of ischemic myocardium. Circulation (1983) 1.01
Ventricular activation patterns of spontaneous and induced ventricular rhythms in canine one-day-old myocardial infarction. Evidence for focal and reentrant mechanisms. Circ Res (1982) 1.00
Ventricular fibrillation caused by myocardial reperfusion in Prinzmetal's angina. Am Heart J (1983) 0.97
Suppression of repolarization-related arrhythmias in vitro and in vivo by low-dose potassium channel activators. Circulation (1990) 0.94
Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels. J Cardiovasc Pharmacol (1992) 0.91
Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation. Am J Physiol (1993) 0.89
Antiarrhythmic actions of the ATP-regulated K+ current activated by pinacidil. Circ Res (1991) 0.87
Marked action potential prolongation as a source of injury current leading to border zone arrhythmogenesis. Am Heart J (1994) 0.87
Glibenclamide does not prevent action potential shortening induced by ischemia in anesthetized rabbits but reduces ischemia-induced arrhythmias. J Mol Cell Cardiol (1998) 0.86
Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts? J Pharmacol Exp Ther (1993) 0.86
ATP-sensitive potassium channels and myocardial ischemia: why do they open? Cardiovasc Drugs Ther (1992) 0.86
Concerning the effect of the K+ channel blocking agent glibenclamide on ischaemic and reperfusion arrhythmias. Eur J Pharmacol (1997) 0.85
Differential effects of glyburide on premature beats and ventricular tachycardia in an isolated tissue model of ischemia and reperfusion. J Pharmacol Exp Ther (1992) 0.84
K+ ATP-channel opening and arrhythmogenesis. J Cardiovasc Pharmacol (1994) 0.83
Nicorandil suppresses early afterdepolarisation and ventricular arrhythmias induced by caesium chloride in rabbits in vivo. Cardiovasc Res (1991) 0.83
Activation of cardiac KATP channels: an endogenous protective mechanism during repetitive ischemia. Am J Physiol (1993) 0.82
Nicorandil reduces myocardial infarct size by opening the K(ATP) channel in rabbits. Int J Cardiol (1997) 0.82
Electrophysiological responses of hypertrophied rat myocardium to combined hypoxia, hyperkalemia, and acidosis. J Cardiovasc Pharmacol (1991) 0.81
Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies. J Mol Cell Cardiol (1997) 0.81
Ischemic myocardial cell protection conferred by the opening of ATP-sensitive potassium channels. Cardiovasc Drugs Ther (1995) 0.81
KATP channel modulators and myocardial damages induced by ischemia-reperfusion: membrane lipids injury and arrhythmias. J Mol Cell Cardiol (1998) 0.80
Multivariate prediction of spontaneous repetitive responses in ventricular myocardium exposed in vitro to simulated ischemic conditions. Int J Cardiol (1994) 0.80
The dispersion of repolarization in patients with ventricular tachycardia. A study using simultaneous monophasic action potential recordings from two sites in the right ventricle. Eur Heart J (1995) 0.80
Role for ATP-sensitive K+ channel in the development of A-V block during hypoxia. J Mol Cell Cardiol (1995) 0.79
Proarrhythmic effects of DL- and D-sotalol on the "border zone" between normal and ischemic regions of isolated ventricular myocardium and antiarrhythmic effects on reperfusion. J Cardiovasc Pharmacol (1998) 0.79
Electrophysiologic effects of potassium channel openers. Cardiovasc Drugs Ther (1995) 0.79
Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia. Cardiovasc Res (1994) 0.78
Cardioprotective effects of NIP-121, a novel ATP-sensitive potassium channel opener, during ischemia and reperfusion in coronary perfused guinea pig myocardium. J Cardiovasc Pharmacol (1996) 0.77
Effects of intracoronary glyburide on cesium-induced arrhythmias in anesthetized dogs. J Cardiovasc Pharmacol (1994) 0.77
Repolarization interactions between cardiac segments of varying action potential duration. Am Heart J (1989) 0.77
[The prevention of an excitation-conduction block during acute myocardial ischemia: is there a role for prostacyclin or for histamine?]. Cardiologia (1991) 0.77
The links between basic and clinical cardiac electrophysiology. Circulation (1988) 0.77
Interaction between a normoxic and a hypoxic region of guinea pig and ferret papillary muscles. Circ Res (1985) 0.76
Effect of glibenclamide on the metabolism of fatty acids in cultures of newborn rat heart cells under normoxic and hypoxic conditions. Prostaglandins Leukot Essent Fatty Acids (1995) 0.76
Proarrhythmic and antiarrhythmic effects of bupivacaine in an in vitro model of myocardial ischemia and reperfusion. Anesthesiology (1998) 0.76
Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J (2000) 2.90
Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology (1997) 2.15
Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart (2000) 2.05
Muscarinic modulation of cardiac rate at low acetylcholine concentrations. Science (1989) 2.01
Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study. Br J Anaesth (2006) 1.64
[Hypothermia after spinal anaesthesia: implication of morphine?]. Ann Fr Anesth Reanim (2005) 1.42
In vitro effects of desflurane, sevoflurane, isoflurane, and halothane in isolated human right atria. Anesthesiology (2000) 1.41
US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology (1986) 1.25
Aggregation, stability, and formulation of human antibody therapeutics. Adv Protein Chem Struct Biol (2011) 1.22
Hypocaloric high-protein diet improves glucose oxidation and spares lean body mass: comparison to hypocaloric high-carbohydrate diet. Metabolism (1994) 1.22
Twenty-five-year coronary mortality trends in the seven countries study using the accelerated failure time model. Eur J Epidemiol (2003) 1.19
Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar. Trans R Soc Trop Med Hyg (1997) 1.15
The effect of quinidine on membrane electrical activity in frog auricular fibres studied by current and voltage clamp. Br J Pharmacol (1976) 1.11
Twenty-five-year cardiovascular disease incidence among middle-aged men. Disease burden, time shape, predictors, risk probabilities. Ital Heart J (2000) 1.10
Non-invasive continuous arterial pressure and cardiac index monitoring with Nexfin after cardiac surgery. Br J Anaesth (2012) 1.07
Acute disseminated intravascular coagulation syndrome in cancer patients. Oncology (1995) 1.07
Small hepatocellular carcinoma: percutaneous alcohol injection--results in 23 patients. Radiology (1988) 1.06
Assessment of flow velocity reserve by transthoracic Doppler echocardiography and venous adenosine infusion before and after left anterior descending coronary artery stenting. J Am Coll Cardiol (2001) 1.03
Pollen discrimination and classification by Fourier transform infrared (FT-IR) microspectroscopy and machine learning. Anal Bioanal Chem (2009) 0.98
Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse. Am J Med (1982) 0.96
Prediction of sudden death from QTc interval prolongation in patients with chronic ischemic heart disease. J Electrocardiol (1986) 0.95
Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid. J Cardiovasc Surg (Torino) (1996) 0.94
Transglutaminase activity during senescence and programmed cell death in the corolla of tobacco (Nicotiana tabacum) flowers. Cell Death Differ (2002) 0.93
Torsion of the human left ventricle: experimental analysis and computational modeling. Prog Biophys Mol Biol (2011) 0.90
Desflurane affords greater protection than halothane against focal cerebral ischaemia in the rat. Br J Anaesth (2003) 0.90
[Fulminant influenza type A associated myocarditis: a fatal case in an 8 year old child]. Arch Mal Coeur Vaiss (2006) 0.90
[Traumatic rupture of the pericardium. A rare diagnosis]. Ann Fr Anesth Reanim (1998) 0.90
Insulin enhances endothelial alpha2-adrenergic vasorelaxation by a pertussis toxin mechanism. Hypertension (1997) 0.88
Radioimmunoassay for plasma histamine: a study of false positive and false negative values. Br J Anaesth (1995) 0.88
The shape of human atrial action potential accounts for different frequency-related changes in vitro. Int J Cardiol (1996) 0.87
Potential of telomerase expression and activity in cervical specimens as a diagnostic tool. J Clin Pathol (2005) 0.86
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Ann Oncol (2008) 0.85
An elongation factor Tu (EF-Tu) resistant to the EF-Tu inhibitor GE2270 in the producing organism Planobispora rosea. Mol Microbiol (1996) 0.85
Synthesis of sub-micromolar inhibitors of MraY by exploring the region originally occupied by the diazepanone ring in the liposidomycin structure. Bioorg Med Chem Lett (2002) 0.85
Handgrip increases endothelin-1 secretion in normotensive young male offspring of hypertensive parents. J Am Coll Cardiol (1998) 0.84
Cicletanide improves outcome after left circumflex coronary artery occlusion-reperfusion in the dog. J Cardiovasc Pharmacol (1986) 0.84
The risk of myocardial stunning is decreased concentration-dependently by KATP channel activation with nicorandil before high K+ cardioplegia. Int J Cardiol (1995) 0.83
Molsidomine prevents post-ischaemic ventricular fibrillation in dogs. Br J Pharmacol (1986) 0.83
Prognosis and prediction of response in breast cancer: the current role of the main biological markers. Cell Prolif (1998) 0.82
Voltage criteria of left ventricular hypertrophy in sudden and nonsudden coronary artery disease mortality: the Italian section of the Seven Countries Study. Am J Cardiol (1990) 0.82
Corticosteroids as adjunctive treatment in Austrian's syndrome (pneumococcal endocarditis, meningitis, and pneumonia): report of two cases and review of the literature. J Clin Pathol (2003) 0.81
Purpuromycin: an antibiotic inhibiting tRNA aminoacylation. RNA (1997) 0.81
Prevention of postischaemic ventricular fibrillation by long term beta adrenoceptor blockade with acebutolol in the anaesthetised dog. Cardiovasc Res (1986) 0.81
Delayed diagnosis of vascular injuries during lumbar discectomy. J Clin Anesth (2000) 0.81
Electrophysiological responses of hypertrophied rat myocardium to combined hypoxia, hyperkalemia, and acidosis. J Cardiovasc Pharmacol (1991) 0.81
Polynucleotide:Adenosine glycosidase is the sole activity of ribosome-inactivating proteins on DNA. J Biochem (2000) 0.81
KATP channel modulators and myocardial damages induced by ischemia-reperfusion: membrane lipids injury and arrhythmias. J Mol Cell Cardiol (1998) 0.80
QT interval prolongation and increased plasma catecholamine levels in patients with mitral valve prolapse. Am Heart J (1983) 0.80
Multivariate prediction of spontaneous repetitive responses in ventricular myocardium exposed in vitro to simulated ischemic conditions. Int J Cardiol (1994) 0.80
[Vasodilatory septic shock refractory to catecholamines: is there a role for terlipressin?]. Ann Fr Anesth Reanim (2003) 0.80
Proarrhythmic effects of DL- and D-sotalol on the "border zone" between normal and ischemic regions of isolated ventricular myocardium and antiarrhythmic effects on reperfusion. J Cardiovasc Pharmacol (1998) 0.79
Impact of the Gubbio population study on community control of blood pressure and hypertension. Gubbio Study Research Group. J Hypertens (2001) 0.79
First risk functions for prediction of coronary and cardiovascular disease incidence in the Gubbio Population Study. Ital Heart J (2000) 0.79
An Italian chart for cardiovascular risk prediction. Its scientific basis. Ann Ital Med Int (2002) 0.79
Sudden death in two patients with variant angina and apparently minimal fixed coronary stenoses. J Electrocardiol (1983) 0.79
[Intraoperative memory. A study of its incidence in general anesthesia in 326 patients]. Ann Fr Anesth Reanim (2001) 0.78
Enoximone coupled to very low dose dobutamine echocardiography detects myocardial viability in akinetic and dyskinetic post-myocardial infarcted areas. Am J Cardiol (1999) 0.78
[The blood level of uric acid as a risk factor in transient cerebral ischemic attacks and in non-embolic acute cerebral infarct]. Riv Neurol (1983) 0.78
Early diagnosis of anaphylactic reactions to neuromuscular blocking drugs. Br J Anaesth (1992) 0.78
Electrophysiological effects of butoprozine on isolated heart preparations. Comparison with amiodarone and verapamil. Arch Int Pharmacodyn Ther (1982) 0.78
Effects of butoprozine on ionic currents in frog atrial and ferret ventricular fibres. Comparison with amiodarone and verapamil. Arch Int Pharmacodyn Ther (1982) 0.78
Adenosine triphosphate-dependent potassium channel modulation and cardioplegia-induced protection of human atrial muscle in an in vitro model of myocardial stunning. J Thorac Cardiovasc Surg (2000) 0.78
Electrophysiological effects of dofetilide in an in vitro model of "border zone" between normal and ischemic/reperfused myocardium. Circulation (2000) 0.78
QT interval measurement by a computer assisted program: a potentially useful clinical parameter. J Electrocardiol (1982) 0.78
Pretreatment with the adenosine triphosphate-sensitive potassium channel opener nicorandil and improved myocardial protection during high-potassium cardioplegic hypoxia. J Thorac Cardiovasc Surg (1994) 0.78
Activation of ATP-dependent K+ channels enhances myocardial protection due to cold high potassium cardioplegia: a force-frequency relationship study. J Mol Cell Cardiol (1995) 0.77
Lifestyle habits and mortality from all and specific causes of death: 40-year follow-up in the Italian Rural Areas of the Seven Countries Study. J Nutr Health Aging (2014) 0.77
Prolonged electrical systole in acute myocardial infarction. J Electrocardiol (1980) 0.77
Desflurane-induced postconditioning of diabetic human right atrial myocardium in vitro. Diabetes Metab (2009) 0.77
Double-blind, placebo-controlled, randomized, crossover trial of high-dose methylprednisolone in patients with chronic progressive form of multiple sclerosis. Eur Neurol (1995) 0.77
Patterns of Pap smear use in the Rimini area: an analysis of women's attitudes to the test. Eur J Cancer Prev (1993) 0.77
Cardioprotective effects of desflurane: effect of timing and duration of administration in rat myocardium. Br J Anaesth (2004) 0.77
[The prevention of an excitation-conduction block during acute myocardial ischemia: is there a role for prostacyclin or for histamine?]. Cardiologia (1991) 0.77
Can the mode of death be predicted in patients with angiographically documented coronary artery disease? Clin Cardiol (1983) 0.77
A case of hypocalcemia-related epilepsia partialis continua. Seizure (2011) 0.77
The QT-sensitive cybernetic pacemaker: a new role for an old parameter? Pacing Clin Electrophysiol (1986) 0.77
Differential effects of ACh on cardiac pacemaker cells. Trends Neurosci (1992) 0.77
Platelet activation and cytokine production during hypothermic cardiopulmonary bypass--a possible correlation? Thromb Haemost (1998) 0.77
The clinical picture of diabetic retinopathy in the dog. Folia Vet Lat (1977) 0.77
The circumflex coronary artery occlusion canine model of sudden death: methodology and electrocardiographic observations. J Electrocardiol (1986) 0.77
Hemodynamic effects of hydroxocobalamin in conscious dogs. Anesthesiology (1991) 0.76
Proarrhythmic and antiarrhythmic effects of bupivacaine in an in vitro model of myocardial ischemia and reperfusion. Anesthesiology (1998) 0.76
The in vitro effects of remifentanil, sufentanil, fentanyl, and alfentanil on isolated human right atria. Anesth Analg (2001) 0.76